MicroPort Medical (00853.HK) Forecasts 40%-60% Net Profit Growth for HeartMed Tech in 2020
MicroPort
High-end Medical Device R&D and Manufacturer
Endovastec
Developer and Manufacturer of Aortic and Peripheral Vascular Interventional Medical Devices
Original Title: MicroPort (00853.HK) ExpectsEndovastecMicroPort’s Full-Year Net Profit Grows 40%-60% Source: AAFN
MicroPort announced that Endovastec is expected to report its 2020 annualNet ProfitRMB 198 million to RMB 227 million, representing a year-on-year growth of 40%-60%, primarily driven by the steady progress of major new products launched in recent years in tendering and hospital admission processes, maintaining a strong growth momentum in sales revenue; as well as certain interest income from cash management and receipt of various government subsidies. Currently, the company holds a 46.34% equity stake in Endovastec. (de/d) ~ AASTOCKS Financial News Website: www.aastocks.com